| Primary information |
|---|
| CancerPDF_ID | CancerPDF_ID9462 |
| PMID | 26379225 |
| Peptide Sequence | MEPLGRQLTSGP |
| Peptide Sequence in Publication | MEPLGRQLTSGP |
| Protein Name | Alpha-2-antiplasmin |
| UniprotKB Entry Name | A2AP_HUMAN |
| Biofluid | Plasma |
| M/Z | 1285.66 |
| Charge | NA |
| Mass/H+ | NA |
| Mass (in Daltons) | NA |
| Profiling Technique | MALDI-TOF |
| Peptide Identification Technique | MALDI-TOF/TOF |
| Quantification Technique | NA |
| Labeling | Label Free |
| FDR | NA |
| p-Value | NA |
| Software | MASCOT (v 2.3) |
| Length of Peptide | 12 |
| Cancer Type | Colorectal cancer |
| Database for Peptide search | UniprotKB |
| Modification | NA |
| Number of Patients | "94 patients with CRC, 23 with liver metastasis from CRC (histologically defined) and 34 subjects, which underwent colonoscopy and resulted negative" |
| Regulation/Differential Expression | Lower intensity in liver metastasis than control groups and an opposite trend in adenoma and CRC group. |
| Validation | NA |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| Secondary information |
|---|
| Peptide Atlas | NA |
| IEDB | |